Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Elevance Health, Inc. before investing.

In this article, we go over a few key elements for understanding Elevance Health, Inc.’s stock price such as:

• Elevance Health, Inc.’s current stock price and volume
• Why Elevance Health, Inc.’s stock price changed recently
• Upgrades and downgrades for ELV from analysts
• ELV’s stock price momentum as measured by its relative strength

About Elevance Health, Inc. (ELV)

Before we jump into Elevance Health, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Want to learn more about Elevance Health, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Elevance Health, Inc..

Elevance Health, Inc.’s Stock Price as of Market Close

As of October 28, 2026, 4:00 PM, CST, Elevance Health, Inc.’s stock price was $414.410.

Elevance Health, Inc. is down 1.68% from its previous closing price of $421.490.

During the last market session, Elevance Health, Inc.’s stock traded between $411.310 and $424.580. Currently, there are approximately 216.60 million shares outstanding for Elevance Health, Inc..

Elevance Health, Inc.’s price-earnings (P/E) ratio is currently at 18.0, which is low compared to the Health Care Providers & Services industry median of 26.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Elevance Health, Inc. Stock Price History

Elevance Health, Inc.’s (ELV) price is currently up 6.58% so far this month.

During the month of October, Elevance Health, Inc.’s stock price has reached a high of $450.690 and a low of $375.740.

Over the last year, Elevance Health, Inc. has hit prices as high as $450.690 and as low as $274.840. Year to date, Elevance Health, Inc.’s stock is up 18.22%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Elevance Health, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 27, 2026, there were 0 analysts who downgraded Elevance Health, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Elevance Health, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Elevance Health, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Elevance Health, Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Elevance Health, Inc. (ELV) by visiting AAII Stock Evaluator.

Relative Price Strength of Elevance Health, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of October 27, 2026, Elevance Health, Inc. has a weighted four-quarter relative price strength of 3.55%, which translates to a Momentum Score of 72 and is considered to be Strong.

Want to learn more about how Elevance Health, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Elevance Health, Inc. Stock Price: Bottom Line

As of October 28, 2026, Elevance Health, Inc.’s stock price is $414.410, which is down 1.68% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Elevance Health, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.